Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to September 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $376.6M |
| Sales growthchange from the year before | +20.3% |
| Gross marginshare of sales left after the direct cost of what it sells | 50.7% |
| Operating marginshare of sales left after running the business | -36.2% |
| Net marginshare of sales kept as profit | -20.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | -20.1% |
| Return on invested capitalprofit made on each $100 put into the business | -23.6% |
| Return on equityprofit vs. shareholders' accounting value | -17.0% |
| Change in share countnegative = the company is buying back its shares | +3.1% |
5 insiders sold $1.1M on the open market.
| Cho DennisSee Remarks | SoldAug 3 | 1,070 shat $85.32 · $91K |
| Werner Robert F.Chief Accounting Officer | SoldAug 3 | 167 shat $85.32 · $14K |
| Leproust Emily M.Chief Executive Officer · Director | SoldAug 3 | 5,101 shat $85.32 · $435K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy